Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tobacco settlement bill with smoking cessation "voucher" program passes Senate cmte.

This article was originally published in The Tan Sheet

Executive Summary

SMOKING CESSATION PRODUCT GRANTS TO PUBLIC ENTITIES, INDIVIDUALS are among the health provisions of Sen. John McCain's (R-Ariz.) Tobacco Products Control Act (S 1415). The substitute legislation passed the Senate Commerce Committee by a 19-1 vote April 1; in addition to McCain's substitute amendment, there were 17 amendments added to the bill. However, the version cleared by the committee contains identical smoking cessation provisions as the original bill introduced by the Arizona Republican in November. Under the terms of S 1415, grants for smoking cessation programs could be awarded not only to "eligible public and nonprofit entities" but also to individuals.

You may also be interested in...



People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

UsernamePublicRestriction

Register

PS088299

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel